Results 241 to 250 of about 297,437 (356)

Diagnosis and Treatment of Adolescent Polycystic Ovary syndrome:A Review. [PDF]

Int J Womens Health
Zhang Y, Yang K, Fan T, Zheng D, Liu H.
europepmc   +1 more source

Evaluating the Cutaneous Manifestations and Associated Comorbidities of Childhood Obesity

Pediatric Dermatology, EarlyView.
ABSTRACT Rates of childhood obesity are rising, making it a public health concern due to its link to numerous poor health outcomes over the lifespan. In adults, obesity is associated with various inflammatory skin conditions; however, this is not well‐studied in children with obesity.
Samantha Epstein, Sonal D. Shah
wiley   +1 more source

International evidence-based recommendations for polycystic ovary syndrome in adolescents. [PDF]

BMC Med
Peña AS, Witchel SF, Boivin J, Burgert TS, Ee C, Hoeger KM, Lujan ME, Mousa A, Oberfield S, Tay CT, Teede H.   +10 more
europepmc   +1 more source

Photodynamic priming overcomes platinum resistance from short‐term exposure to select perfluoroalkyl substances in endometrial cancer cell lines

Photochemistry and Photobiology, EarlyView.
PFAS are widespread environmental contaminants that are associated with platinum resistance and mitochondrial membrane hyperpolarization in endometrial cancer cell lines. Photodynamic therapy, using BPD or ALA‐PpIX, in combination with low‐dose carboplatin overcomes PFAS‐induced platinum resistance in endometrial cancer cell lines.
Brittany P. Rickard, Lauren A. Sapienza‐Lundie, Marta Overchuk, Xianming Tan, Victoria L. Bae‐Jump, Melinda S. Yates, Suzanne E. Fenton, Imran Rizvi   +7 more
wiley   +1 more source

Consistency of endothelial function across two consecutive oral contraceptive pill cycles

Experimental Physiology, EarlyView.
Abstract Oral contraceptive pills (OCPs), composed of an active pill (AP; synthetic hormone) and a placebo pill (PP; synthetic hormone‐free) phase, might impact endothelial function across the OCP cycle depending on the synthetic hormone composition (type and dose).
Lindsay A. Lew, Desiree Tugwell, Tess Leavitt, Melanie Vitez, Emily J. Ferguson, Kyra E. Pyke   +5 more
wiley   +1 more source

The Influence of Subclinical Hypothyroidism on Endocrine and Metabolic Characteristics in Patients with Polycystic Ovary Syndrome. [PDF]

Int J Womens Health
Dai F, Wu Z, Qin S, Wu F, Wang M, Liu X, Liu F.   +6 more
europepmc   +1 more source

Octreotide is not useful for clomiphene citrate resistance in patients with polycystic ovary syndrome but may reduce the likelihood of ovarian hyperstimulation syndrome [PDF]

, 1999
Randy S. Morris, Vishvanath Karande, Alan B. Dudkiewicz, Jody L Morris, Norbert Gleicher   +4 more
openalex   +1 more source

Bioavailable testosterone and androgen receptor activation, but not total testosterone, are associated with muscle mass and strength in females

The Journal of Physiology, EarlyView.
Abstract figure legend Twenty‐seven pre‐menopausal, untrained females performed a 12‐week resistance training programme to explore the association between androgen concentrations, androgen receptor signalling and skeletal muscle size and strength. Total testosterone was not associated with muscle mass or strength, nor with resistance training‐induced ...
Sarah E. Alexander, Briana Gatto, Olivia E. Knowles, Ross M. Williams, Kinga N. Fiebig, Paul Jansons, Paul A. Della Gatta, Andrew Garnham, Nir Eynon, Glenn D. Wadley, Brad Aisbett, Danielle Hiam, Séverine Lamon   +12 more
wiley   +1 more source

Wilson disease combined with polycystic ovary syndrome-clinical features, treatment, and outcome in Chinese patients. [PDF]

BMC Endocr Disord
Chen L, Fang MJ, Zhang LL, Liu YF, Han YZ, Yu XE, Xu Y.   +6 more
europepmc   +1 more source

Restoration of Reproductive Potential by Lifestyle Modification in Obese Polycystic Ovary Syndrome: Role of Insulin Sensitivity and Luteinizing Hormone1 [PDF]

, 1999
M.-M. Huber-Buchholz, D. Carey, Robert J. Norman   +2 more
openalex   +1 more source